Pelvic Floor Dysfunction
Conditions
Interventions
Sponsors
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age range of 18-75 years old, knowledge of the study, voluntary participation in the study, and signing of informed consent form; 2. Patients with vaginal laxity (self perceived vaginal laxity, unsatisfactory sexual life); 3. Patients with complex urinary incontinence (according to the International Urinary Control Association diagnostic criteria, conservative treatment for urinary incontinence is ineffective for >= 3 months, such as pelvic floor muscle rehabilitation training), including: (1) Urgency urinary incontinence; (2) Mixed urinary incontinence mainly characterized by mild stress urinary incontinence; (3) Severe stress urinary incontinence with no surgical intention at present; (4) Patients with mild to moderate stress urinary incontinence after surgical treatment, but no intention of surgery at present; 4. Patients with symptomatic mild to moderate pelvic organ prolapse (POP) who have not undergone pelvic floor surgery in the past, including: (1) Patients with symptoms such as frequent urination, urgency to urinate, lower abdominal distension, and abnormal bowel movements, and with POP-Q<stage III; (2) Mild to moderate POP patients with ineffective or ineffective pelvic floor magnetic stimulation rehabilitation therapy (POP-Q<stage III, Kegel exercise, pelvic floor electrical stimulation or magnetic stimulation at least 10 times, muscle strength improvement of less than 1 level and Glazer single parameter score improvement of less than 10 points 3 months after treatment); (3)Patients with old partial or complete rupture of the levator ani muscle who have no intention of surgery.
Exclusion criteria
Exclusion criteria: 1. Combine psychiatric and neurogenic diseases diagnosed by specialized doctors; 2. Acute urinary and reproductive system infections, tuberculosis, bleeding, or reproductive tract abnormalities; 3. Internal medicine comorbidities such as severe hypertension, liver and kidney dysfunction, or important organ failure; 4. Combining gynecological malignant tumors, previous surgical treatment for cervical cancer, endometrial cancer, ovarian cancer, or pelvic radiation therapy history; 5. Severe pelvic organ prolapse (POP-Q >= stage III); 6. Pregnancy or planned pregnancy; 7. Abnormal uterine bleeding without clear diagnosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pelvic floor electromyography;Pelvic floor muscle strength;Pelvic floor POP-Q score;Pelvic Floor Dysfunction Questionnaire, PFDI-20;Pelvic Floor Disorders Impact Brief Questionnaire, PFIQ-7; | — |
Secondary
| Measure | Time frame |
|---|---|
| Vaginal width;1-hour urine pad experiment; | — |
Countries
China
Contacts
Public ContactMingfu Wu
Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
Outcome results
None listed